Skip to content

Silvia Natoli

2 papers in the library · publishing 2007-2025

Papers

Sort Most recent Most cited

Psilocybin and Chronic Pain: A New Perspective for Future Pain Therapists?

Medical Sciences November 20, 2025 Silvia Natoli, Arturo Cuomo, Maurizio Marchesini et al.

Background: Chronic pain affects nearly one in five adults worldwide and remains a major healthcare burden due to its persistence, multidimensional impact, and resistance to conventional therapies. The opioid crisis has further highlighted the urgent need for safer and more effective alternatives. Psilocybin, a serotonergic psychedelic compound, has re-emerged as a potential therapeutic option...

DOI: 10.3390/medsci13040277 (opens in new tab) Psilocybin Perspective graphical Chronic pain Clinical trial +7

Electrophysiologic changes in ventral midbrain dopaminergic neurons resulting from (+/-) -3,4-methylenedioxymethamphetamine (MDMA-"Ecstasy").

Biological Psychiatry September 15, 2007 Mauro Federici, Luca Sebastianelli, Silvia Natoli et al.

Although dopamine (DA) has been implicated in the psychostimulant properties of 3,4-methylenedioxymethamphetamine (MDMA), there is no detailed information on its modalities of action on single ventral midbrain dopaminergic neurons. We examined the actions of MDMA on intracellularly recorded dopaminergic neurons maintained in slices. At 1 micromol/L, MDMA depolarized and excited the cells; at 3...